2013
Eli Lilly v. Canada
Eli Lilly and Company v. Canada
(ICSID Case No. UNCT/14/2)
Canada
United States of America
Patents for two pharmaceutical products, Strattera and Zyprexa.
Claims arising out of the invalidation of the claimant's Strattera and Zyprexa pharmaceutical patents by Canada.
Secondary: C - Manufacturing
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
UNCITRAL
ICSID (International Centre for Settlement of Investment Disputes)
van den Berg, A. J.
Born, G. B.
Bethlehem, D.
Decided in favour of State
500.00 mln CAD (483.40 mln USD)
Data not available
Indirect expropriation
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims
None - all claims dismissed at the merits stage
http://www.state.gov/s/l/c63964.htm
http://www.international.gc.ca/trade-agreements-accords-commerciaux/topics-domaines/disp-diff/eli.aspx?lang=eng
http://globalarbitrationreview.com/news/article/31899/canada-faces-drug-patents-claim/ (requires subscription)
http://www.iareporter.com/articles/20140409 (requires subscription)
https://icsid.worldbank.org/en/Pages/cases/casedetail.aspx?CaseNo=UNCT/14/2
https://www.iareporter.com/articles/in-depth-in-now-public-final-award-tribunal-sees-no-dramatic-change-in-canadian-patent-law-to-ground-eli-lillys-claims-of-nafta-breach/ (requires subscription)
http://globalarbitrationreview.com/article/1138486/canadian-patent-law-not-a-dramatic-change-rules-eli-lilly-tribunal (requires subscription)
http://globalarbitrationreview.com/article/1138461/canada-defeats-nafta-claim-over-pharma-patents (requires subscription)
https://www.transnational-dispute-management.com/downloads/17561_case_report_eli_lilly_v_canada_-_award.pdf
http://www.international.gc.ca/trade-agreements-accords-commerciaux/topics-domaines/disp-diff/eli.aspx?lang=eng
http://globalarbitrationreview.com/news/article/31899/canada-faces-drug-patents-claim/ (requires subscription)
http://www.iareporter.com/articles/20140409 (requires subscription)
https://icsid.worldbank.org/en/Pages/cases/casedetail.aspx?CaseNo=UNCT/14/2
https://www.iareporter.com/articles/in-depth-in-now-public-final-award-tribunal-sees-no-dramatic-change-in-canadian-patent-law-to-ground-eli-lillys-claims-of-nafta-breach/ (requires subscription)
http://globalarbitrationreview.com/article/1138486/canadian-patent-law-not-a-dramatic-change-rules-eli-lilly-tribunal (requires subscription)
http://globalarbitrationreview.com/article/1138461/canada-defeats-nafta-claim-over-pharma-patents (requires subscription)
https://www.transnational-dispute-management.com/downloads/17561_case_report_eli_lilly_v_canada_-_award.pdf